3‐(Pyridin‐2‐yl)imidazo[1,5‐a]pyridine (Pyridylindolizine) as Ligand in Complexes of Transition and Main‐Group Metals

Producción CientíficaThe coordination of the easily prepared 3‐(pyridin‐2‐yl)imidazo[1,5‐a]pyridine (pyridylindolizine, Py‐indz) ligand to several metal moieties was studied, and its electronic properties, similar to those of the classical ligands 2,2′‐bipyridine (bipy) and 1,10‐phenanthroline (phen), are reported. The new complexes were prepared and fully characterized by X‐ray crystallography and other typical spectroscopic methods if possible. Paramagnetic complexes [Ni(S2X)2(Py‐indz)] X = P(OEt)2 (1), COEt (2); [Ni(acac)2(Py‐indz)] (3, acac = acetylacetonate); [Ni(Py‐indz)3](PF6)2 (4); [Mn2Cl4(Py‐indz)2] (6); and [MnCl2(Py‐indz)2] (7) have the magnetic moment expected for a metallic cation with two or five unpaired electrons. Diamagnetic complexes show NMR spectra with similar patterns with small differences depending on the complex. [M{S2P(OEt)2}2 (Py‐indz)] M = Zn (8), Cd (9) have pentacoordinate and hexacoordinate structures, respectively. Octahedral tin complexes [SnL4(Py‐indz)] L4 = I4 (10), Cl3Ph (11), and Cl2nBu2 (12) have different behaviors in solution; whereas complex 10 is practically insoluble, complex 11 displays the expected pattern in its NMR spectrum, and complex 12 shows dynamic behavior. The Py‐indz ligand is also able to stabilize copper(I) and forms [Cu(PPh3)2(Py‐indz)]BF4 (13). The synthesis of the carbonyl complexes [MBr(CO)3(Py‐indz)] M = Mn (14), Re (15) and [Mo(CO)4(Py‐indz)] (16) was followed by IR spectroscopy in solution. [RuCl·p‐cym(Py‐indz)]PF6 (17, p‐cym = p‐cymene) has the familiar half‐sandwich “three‐legged piano‐stool” geometry.Ministerio de Economía, Industria y Competitividad (Project CTQ2013- 41067-P

Copper Complexes in the Promotion of Aldol Addition to Pyridine-2-carboxaldehyde: Synthesis of Homo- and Heteroleptic Complexes and Stereoselective Double Aldol Addition

Producción CientíficaCuCl2·2H2O and Cu(ClO4)2·6H2O are able to promote aldol addition of pyridine-2-carboxaldehyde (pyca) with acetone, acetophenone, or cyclohexenone under neutral and mild conditions. The general and simple one-pot procedure for the aldol addition to Cu(II) complexes accesses novel Cu complexes with a large variety of different structural motifs, from which the aldol-addition ligand can be liberated by treatment with NH3. Neutral heteroleptic complexes in which the ligand acts as bidentate, or homoleptic cationic complexes in which the ligand acts as tridentate can be obtained depending on the copper salt used. The key step in these reactions is the coordination of pyca to copper, which increases the electrophilic character of the aldehyde, with Cu(ClO4)2 leading to a higher degree of activation than CuCl2, as predicted by DFT calculations. A regio- and stereoselective double aldol addition of pyca in the reaction of Cu(ClO4)2·6H2O with acetone leads to the formation of a dimer copper complex in which the novel double aldol addition product acts as a pentadentate ligand. A possible mechanism is discussed. The work is supported by extensive crystallographic studies.2019-12-312019-12-31Ministerio de Economía, Industria y Competitividad (Project CTQ 2013-41067-P

Influenza A(H5N1) detection in two asymptomatic poultry farm workers in Spain, September to October 2022: suspected environmental contamination

In autumn 2022, the Spanish Influenza National Reference Laboratory (NRL) confirmed the detection of influenza A(H5N1) in samples from two asymptomatic workers linked to an outbreak in a poultry farm in Spain. Nasopharyngeal swabs were taken according to a national screening protocol for exposed workers. Absence of symptoms, low viral load and negative serology in both workers suggested environmental contamination. These findings motivated an update of the early detection strategy specifying timing and sampling conditions in asymptomatic exposed persons.S

Vigilancia del COVID-19 en centros de larga estancia: el efecto de la pandemia en las residencias de mayores

[ES] Este informe muestra la situación epidemiológica de la COVID-19 en los centros residenciales de mayores a lo largo del año 2021 y hasta la semana 17 del 2022. Desde su puesta en marcha en enero de 2021, esta vigilancia ha proporcionado datos semanales nacionales agregados, con información sobre la proporción de residencias afectadas por la COVID-19, la incidencia de COVID-19 y la letalidad entre una población vulnerable donde los efectos de la pandemia han sido y están siendo especialmente graves. La comparación con la incidencia y mortalidad de casos COVID-19 en población mayor no institucionalizada, nos demuestra cómo el impacto de la COVID-19 ha sido y está siendo mayor entre las personas mayores que viven en residencias de ancianos, con tasas de mortalidad superiores al resto de la población de la misma edad. [EN] This report shows the epidemiological situation of COVID-19 in the long-term care facilities (LTCF) for elderly throughout 2021 and until the 17th week of 2022. Since its start-up in January 2021, this surveillance has provided aggregated national weekly data, with information on the proportion of LTCF for elderly affected by COVID-19, the incidence of COVID-19 and fatal cases among a vulnerable population where the effects of the pandemic have been and are being especially severe. The comparison with the incidence and mortality of COVID-19 cases in non institutionalized elderly shows how the impact of COVID-19 is being greater among the elderly living in nursing homes, with more fatal cases than the rest of the population of the same age

Vigilancia epidemiológica de Shigelosis en España, 2016-2021

[ES] Se analizaron los casos y brotes de shigelosis notificados entre los años 2016 y 2021 a la Red Nacional de Vigilancia Epidemiológica (RENAVE), que recoge, entre otra, información relativa a edad y sexo de los casos, posibles mecanismos de transmisión y características microbiológicas de los aislados, aunque no incluye información sobre resistencias antibióticas. Durante el periodo de estudio, se notificaron 1.985 casos y 18 brotes de shigelosis. La incidencia acumulada aumentó en el periodo 2016-2019 (con un máximo de 1,2 casos por 100.000 habitantes en el año 2019), disminuyendo posteriormente durante los años 2020 y 2021, con 0,3 casos por 100.000 habitantes en ambos años. No obstante, en el año 2021, a pesar de que sólo algunas Comunidades Autónomas notificaron casos a la RENAVE, el número de casos fue ligeramente superior al año previo. La enfermedad fue más frecuente en hombres que en mujeres, fundamentalmente en individuos entre 15 y 49 años, siendo estos grupos de edad los que presentaron mayor razón hombre/mujer. La especie de Shigella más aislada durante el periodo de estudio fue S. sonnei, seguida de S. flexneri, aunque no se disponía de información en aproximadamente la mitad de los casos. Únicamente en 9 casos constaba como mecanismo de transmisión las relaciones sexuales, aunque la información sobre el posible mecanismo de transmisión no se recogió en más del 90% de los casos. Es necesario reforzar la notificación de la enfermedad en España, especialmente la información relativa a la transmisión, a la caracterización microbiológica y a las resistencias a los antimicrobianos. [EN] Cases and outbreaks of shigelosis reported from 2016 to 2021 to the National Epidemiological Surveillance Network (RENAVE in Spanish) were analysed, including information about age and sex of cases, possible routes of transmission and microbiological characteristics of isolates, although information about antimicrobial resistance was not reported. During the study period, 1,985 cases and 18 outbreaks of shigelosis were reported. The cumulative incidence raised during 2016-2019 period (with a maximum of 1.2 cases per 100.000 inhabitants in 2019), declining in 2020 and 2021, with 0.3 cases per 100.000 inhabitants both years. Nevertheless, during 2021, although only some Autonomous Regions reported cases to RENAVE, the number of cases was slightly higher than the previous year, due to some regions reporting similar or higher figures than in the pre-pandemic period. The disease was more frequent in men than in women, mainly in individuals from 15 to 49 years old, being these age groups those that presented the highest maleto-female ratio. S. sonnei was the most frequent species of Shigella isolated, followed by S. flexneri, although the information was not available in approximately half of the cases. Sexual transmission was mentioned only in a small percentage of cases, but information about exposure/transmission was not available for more than 90% cases. It is necessary to strengthen the epidemiological surveillance of this disease in Spain, regarding the transmission, microbiological characterization and antimicrobial resistance.N

Propuesta de innovación docente para Filología: programa de inclusión del alumnado en la investigación universitaria y la adquisición de experiencias científicas y formativas

El presente proyecto busca satisfacer la creciente voluntad de participación del alumnado en los procesos y ámbitos académicos profesionales, dinamizando su interacción con el cuerpo docente, así como la apertura de horizontes laborales a nivel universitario. Se incentivará el aprendizaje y la producción personal del alumno mediante la adición de vías participativas más allá de las curriculares, y se reforzará el funcionamiento de aquéllas merced al desarrollo de metodologías donde sus actividades investigadoras y creativas encuentren una respuesta y supervisión más inmediata del profesorado. Estas iniciativas pavimentarán las futuras incursiones académicas del alumno que desee realizarlas y supondrán una mejora en los planteamientos teóricos y prácticos del que participan el resto. Es un proyecto que emana de iniciativas ya existentes tanto entre el alumnado como entre el cuadro docente; sus repercusiones, aunque académicas, son eminentemente prácticas, en tanto que revitalizan la utilidad intelectual, personal y académica del grado y conectan los conocimientos de éste con las ramificaciones que un personal docente transversal es capaz de ofrecer

Long-term care facilities (LTCF) for the elderly: the surveillance of communicable diseases as part of health care and protection

[ES] Durante las últimas décadas la asistencia sanitaria ha sufrido importantes cambios. La mayor esperanza de vida ha dado lugar a un envejecimiento de la población que, según las Naciones Unidas, está a punto de convertirse en una de las más importantes transformaciones sociales del siglo XXI. A nivel mundial, había 727 millones de personas de 65 años o más en 2020 (un 9,3% de la población total) y se estima que aumente al 16% en 2050 . En la Unión Europea (UE), el porcentaje de población de 65 años o más se ha incrementado de un 9,6% en 1960 a un 20,3% en 2019 y se proyecta que aumente a un 31,3% para 2100. Asistimos además a un proceso de envejecimiento de la población mayor, con una proporción de personas muy mayores (aquellas de 80 años y más) en la población total de la Unión Europea del 5,8% en 2019 . España es uno de los países con una mayor proporción de personas mayores, con un porcentaje de ciudadanos de 65 años o más en 2020 del 19,6% del total de la población, y con una proyección del 26,5% para 2035. Casi un tercio de esta población (6%) tienen 80 años o más. [EN] During the last decades, healthcare has undergone important changes. Increased life expectancy has given rise to an aging population that, according to the United Nations, is about to become one of the most important social transformations of the 21st century. Globally, there were 727 million people aged 65 or over in 2020 (9.3% of the total population) and this is estimated to increase to 16% by 2050 . In the European Union (EU), the percentage of the population aged 65 or over has increased from 9.6% in 1960 to 20.3% in 2019 and is projected to increase to 31.3% by 2100. We are also witnessing a process of aging of the elderly population, with a proportion of very old people (those aged 80 and over) in the total population of the European Union of 5.8% in 2019 . Spain is one of the countries with the highest proportion of older people, with a percentage of citizens aged 65 or over in 2020 of 19.6% of the total population, and with a projection of 26.5% for 2035. Almost a third of this population (6%) are 80 years or older.S

Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination

[EN] Background: This study compares the severity of SARS-CoV-2 infections caused by Alpha, Delta or Omicron variants in periods of co-circulation in Spain, and estimates the variant-specific association of vaccination with severe disease. Methods: SARS-CoV-2 infections notified to the national epidemiological surveillance network with information on genetic variant and vaccination status were considered cases if they required hospitalisation or controls otherwise. Alpha and Delta were compared during June-July 2021; and Delta and Omicron during December 2021-January 2022. Adjusted odds ratios (aOR) were estimated using logistic regression, comparing variant and vaccination status between cases and controls. Results: We included 5,345 Alpha and 11,974 Delta infections in June-July and 5,272 Delta and 10,578 Omicron in December-January. Unvaccinated cases of Alpha (aOR: 0.57; 95% CI: 0.46-0.69) or Omicron (0.28; 0.21-0.36) had lower probability of hospitalisation vs. Delta. Complete vaccination reduced hospitalisation, similarly for Alpha (0.16; 0.13-0.21) and Delta (June-July: 0.16; 0.14-0.19; December-January: 0.36; 0.30-0.44) but lower from Omicron (0.63; 0.53-0.75) and individuals aged 65+ years. Conclusion: Results indicate higher intrinsic severity of the Delta variant, compared with Alpha or Omicron, with smaller differences among vaccinated individuals. Nevertheless, vaccination was associated to reduced hospitalisation in all groups. [ES]Introducción: El objetivo es comprar la gravedad de las infecciones por las variantes Alfa, Delta y Ómicron del SARS-CoV-2 en periodos de co-circulación en España, y estimar la asociación entre vacunación y gravedad en cada variante. Métodos: Las infecciones por SARS-CoV-2 notificadas a la red nacional de vigilancia epidemiológica con información sobre la variante viral y el estado de vacunación se clasificaron como casos si habían requerido hospitalización, o como controles en caso contrario. Alfa y Delta se compararon durante junio-julio de 2021, y Delta y Ómicron durante diciembre de 2021-enero de 2022. Se estimaron odds ratios ajustadas (ORa) mediante regresión logística, comparando la variante y el estado de vacunación entre casos y controles. Resultados: Se incluyeron 5.345 infecciones por variante Alfa y 11.974 por Delta en junio-julio y 5.272 infecciones por Delta y 10.578 por Ómicron en diciembre-enero. Los casos no vacunados por Alfa (aOR: 0,57; IC 95%: 0,46-0,69) u Ómicron (0,28; IC 95%: 0,21-0,36) tuvieron menor probabilidad de hospitalización comparados con Delta. La vacunación completa se asoció a menor hospitalización de forma similar para Alfa (0,16; IC 95%: 0,13-0,21) y Delta (junio-julio: 0,16; IC 95%: 0,14-0,19; diciembre-enero: 0,36; IC 95%: 0,30-0,44) pero menor para Ómicron (0,63; IC 95%: 0,53-0,75) y para individuos con 65+ años. Conclusión: Los resultados indican una mayor gravedad intrínseca de la variante Delta comparada con Alfa u Ómicron, con menor diferencia entre personas vacunadas. La vacunación se asoció a menor hospitalización en todos los grupos.In this study the identification of variants by genomic sequencing has been partially supported by HERA-Incubator ECDC/GRANT/2021/024-Enhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in Spain.S

COVID-19 outbreaks in a transmission control scenario: challenges posed by social and leisure activities, and for workers in vulnerable conditions, Spain, early summer 2020

Severe acute respiratory syndrome coronavirus 2 community-wide transmission declined in Spain by early May 2020, being replaced by outbreaks and sporadic cases. From mid-June to 2 August, excluding single household outbreaks, 673 outbreaks were notified nationally, 551 active (>6,200 cases) at the time. More than half of these outbreaks and cases coincided with: (i) social (family/friends’ gatherings or leisure venues) and (ii) occupational (mainly involving workers in vulnerable conditions) settings. Control measures were accordingly applied

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry

Background: The effectiveness of the switch to another anti-tumor necrosis factor (anti-TNF) agent is not known. The aim of this study was to analyze the effectiveness and safety of treatment with a second and third anti-TNF drug after intolerance to or failure of a previous anti-TNF agent in inflammatory bowel disease (IBD) patients. Methods: We included patients diagnosed with IBD from the ENEIDA registry who received another anti-TNF after intolerance to or failure of a prior anti-TNF agent. Results: A total of 1122 patients were included. In the short term, remission was achieved in 55% of the patients with the second anti-TNF. The incidence of loss of response was 19% per patient-year with the second anti-TNF. Combination therapy (hazard ratio [HR], 2.4; 95% confidence interval [CI], 1.8-3; P < 0.0001) and ulcerative colitis vs Crohn's disease (HR, 1.6; 95% CI, 1.1-2.1; P = 0.005) were associated with a higher probability of loss of response. Fifteen percent of the patients had adverse events, and 10% had to discontinue the second anti-TNF. Of the 71 patients who received a third anti-TNF, 55% achieved remission. The incidence of loss of response was 22% per patient-year with a third anti-TNF. Adverse events occurred in 7 patients (11%), but only 1 stopped the drug. Conclusions: Approximately half of the patients who received a second anti-TNF achieved remission; nevertheless, a significant proportion of them subsequently lost response. Combination therapy and type of IBD were associated with loss of response. Remission was achieved in almost 50% of patients who received a third anti-TNF; nevertheless, a significant proportion of them subsequently lost response